The high co-expression of B7-H3 with HER2 was identified as an independent risk factor for poorer overall survival (OS), and CD47 co-expression was associated with worse outcomes than the expression of either B7-H3 or CD47 alone in tumor samples (p = 0.0007) [84]. Here, CD276 is linked to neoplasm.